Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Potent GH secretatogue series patented by Sumitomo

Dec. 17, 1998

No Comments

Transkaryotic Therapies initiates phase II program for Fabry's disease

Dec. 17, 1998

No Comments

Aradigm initiates U.S. phase II studies of AERx Diabetes Management System

Dec. 17, 1998

No Comments

New antidiabetic agents from Yamanouchi have a dual mechanism of action

Dec. 16, 1998

No Comments

Tularik, Knoll to collaborate on antiobesity R&D

Dec. 16, 1998

No Comments

Next-generation SERM presented by Hoechst Marion Roussel

Dec. 15, 1998

No Comments

Raloxifene evaluated for one year in established postmenopausal osteoporosis

Dec. 14, 1998

No Comments

Japanese ACAT inhibitor is safe and effective in several animal species

Dec. 14, 1998

No Comments

E.U.-wide marketing approval granted for Muse

Dec. 14, 1998

No Comments

SomatoKine provides significant benefit in severe burn trial

Dec. 14, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Potent GH secretatogue series patented by Sumitomo

Transkaryotic Therapies initiates phase II program for Fabry's disease

Aradigm initiates U.S. phase II studies of AERx Diabetes Management System

New antidiabetic agents from Yamanouchi have a dual mechanism of action

Tularik, Knoll to collaborate on antiobesity R&D

Next-generation SERM presented by Hoechst Marion Roussel

Raloxifene evaluated for one year in established postmenopausal osteoporosis

Japanese ACAT inhibitor is safe and effective in several animal species

E.U.-wide marketing approval granted for Muse

SomatoKine provides significant benefit in severe burn trial

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Endocrine/metabolic RSS

Endocrine/metabolic
RSS